MediCult Italia, S.p.A. Sustainability Profile
MediCult Italia, S.p.A., a prominent player in the biotechnology sector, is headquartered in Italy and operates extensively across Europe. Founded in the early 2000s, the company has established itself as a leader in reproductive medicine, specialising in innovative solutions for assisted reproductive technologies (ART). MediCult Italia is renowned for its cutting-edge products, including culture media and laboratory equipment designed to enhance embryo development and improve clinical outcomes. Their commitment to quality and research has positioned them as a trusted partner for fertility clinics and laboratories. With a strong market presence and a reputation for excellence, MediCult Italia continues to drive advancements in reproductive health, contributing significantly to the success of ART practices worldwide.
DitchCarbon Score
How does MediCult Italia, S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MediCult Italia, S.p.A.'s score of 34 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MediCult Italia, S.p.A. currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of The Cooper Companies, Inc., and any relevant emissions data or climate commitments may be inherited from this parent organisation. However, no specific reduction targets or climate pledges have been documented for MediCult Italia, S.p.A. As a subsidiary, it is important to note that MediCult Italia's climate initiatives and performance may align with the broader sustainability goals of The Cooper Companies, Inc. Nonetheless, without explicit emissions data or defined reduction targets, the company's individual climate commitments remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 29,747,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 33,442,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is MediCult Italia, S.p.A.'s Industry?
How Carbon Intensive is MediCult Italia, S.p.A.'s Location?
MediCult Italia, S.p.A.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MediCult Italia, S.p.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
